What are the major adverse effects of tramadol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Important Adverse Effects of Tramadol

Tramadol's most critical adverse effects include seizures (especially at high doses or in predisposed patients), serotonin syndrome (when combined with serotonergic medications), typical opioid side effects (drowsiness, constipation, nausea), and respiratory depression, with particular caution needed in elderly patients and those with hepatic or renal dysfunction. 1, 2, 3

Common Opioid-Related Side Effects

Tramadol produces typical opioid adverse effects, though generally milder than traditional opioids:

  • Gastrointestinal effects: Constipation (21.7%), nausea (12.3%), and vomiting are the most frequently reported 4, 5. Recent evidence confirms tramadol causes opioid-induced bowel dysfunction, prolonging colonic transit time by approximately 9 hours and increasing constipation rates to 40% of treated patients 6.

  • Central nervous system effects: Drowsiness/somnolence (3.8%), dizziness (1.9%), and sedation occur commonly 1, 4, 5. These effects are typically mild to moderate and more prominent during initial treatment than maintenance 5.

Critical Safety Concerns

Seizure Risk

Tramadol lowers the seizure threshold, particularly dangerous at doses exceeding 400 mg/day for immediate-release or 300 mg/day for extended-release formulations 7, 2, 8. The NCCN guidelines specifically recommend lower doses for adults ≥75 years and those with hepatic/renal dysfunction to reduce seizure risk 2. This risk increases in predisposed patients and with high-dose use 1.

Serotonin Syndrome

Tramadol must be used with extreme caution or avoided entirely in patients taking other serotonergic medications including SSRIs, SNRIs, tricyclic antidepressants, and MAO inhibitors 1, 7, 2, 8. This potentially fatal drug interaction results from tramadol's dual mechanism as both an opioid agonist and serotonin-norepinephrine reuptake inhibitor 7. While relatively uncommon in clinical practice, serotonin syndrome represents a serious mortality risk 7.

Respiratory Depression

Respiratory depression occurs with tramadol, particularly when combined with other CNS depressants (alcohol, benzodiazepines, other opioids) 3. The FDA label warns that overdose consequences include CNS depression, respiratory depression, and death 3.

Neuropsychiatric Effects

Recent systematic reviews reveal tramadol causes significant psychological side effects including:

  • Confusion (14.6%) and hallucinations (7.3%) 9
  • Manic episodes, hypomania, and psychosis 10
  • Altered consciousness (13.2%) 9
  • Cognitive impairment, particularly in elderly patients 10

Elderly individuals and those with pre-existing psychiatric conditions face heightened vulnerability 10.

Metabolic and Unexpected Effects

French pharmacovigilance data identified unexpected serious adverse reactions:

  • Hyponatremia
  • Cholestatic hepatitis
  • Serotonin syndrome can occur with tramadol alone in overdose situations 9

Special Population Considerations

Elderly Patients

Older adults (≥75 years) require substantially reduced doses - typically 30-40 mg/day maximum rather than standard dosing 1. They experience increased risk of:

  • Drug accumulation with renal/hepatic dysfunction 7
  • Cognitive effects and sedation 1
  • Falls and fractures (from observational data) 11

Hepatic and Renal Impairment

Dose reduction is mandatory in these populations due to decreased drug clearance and increased accumulation risk 7, 2, 7.

Drug Metabolism Variability

Tramadol exhibits marked variability in drug metabolism, requiring cautious use 2. This pharmacokinetic unpredictability can lead to inconsistent therapeutic effects and adverse event profiles.

Withdrawal Syndrome

Abrupt discontinuation causes withdrawal symptoms including anxiety, sweating, insomnia, rigors, pain, nausea, tremors, diarrhea, and rarely hallucinations or panic attacks 3. Always taper tramadol gradually when discontinuing to avoid withdrawal 3.

Abuse and Overdose Potential

While tramadol has lower abuse potential than traditional opioids 7, it remains a mu-opioid agonist subject to misuse 3. Overdose deaths have been reported, especially when combined with alcohol or other CNS depressants 3. Naloxone reverses some but not all overdose symptoms and paradoxically increases seizure risk 3.

Clinical Monitoring Priorities

Monitor specifically for:

  • Bowel function (constipation management essential) 6
  • Mental status changes, especially in elderly 1, 10
  • Concurrent serotonergic medication use 1, 7, 2
  • Seizure history or predisposition 1, 2
  • Respiratory status when combined with CNS depressants 3

References

Guideline

pharmacological management of persistent pain in older persons.

Journal of the American Geriatrics Society (JAGS), 2009

Guideline

adult cancer pain, version 2.2025, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2025

Guideline

adult cancer pain, version 3.2019, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.